Optimum Expands its Team with Senior Investor Relations and Communications Hires Jonathan Edwards and Hana Malik

14 February 2023 – Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announces that it has hired Jonathan Edwards and Hana Malik, two highly experienced investor relations and communications professionals, to join as permanent members of its team. Edwards and Malik have joined Optimum as Account Directors and will be advising clients across […]

2022 | Optimum’s Year in Review

It’s nearly the end of 2022! It was an exciting year for Optimum’s clients which demonstrated the resilience and creativity that has made the life sciences industry so successful. We have outlined below a small fraction of the activity that has kept us busy this year: Deal, deals, deals As usual, 2022 was a year […]

LSX and Jefferies – Insights from the busiest week in European biotech 

The LSX Inv€$tival Showcase kicked off a hectic week in life sciences on 15 November, with these two key events in the biotech calendar making one of the busiest weeks of the year.  Investors and biotechs saw this as a vital chance to meet up and discuss strategies and potential deals amid these dicey market […]

Panel Summaries from Optimum’s 14th Annual Healthcare Investor Conference 2022

For those that were unable to attend on Optimum’s 14th Annual Healthcare Investor Conference, or indeed would like a recap of what was shared on the day, we have been releasing the top takeaways from the panels!   Our first panel of the day, chaired by Stephen Hansen, from BioCentury, saw a panel of blue chip […]

Dan Mahony & Gareth Powell – Global healthcare investing: Can hindsight hone the crystal ball for the future? A fireside chat moderated by Amy Brown, Evaluate Vantage

Dan Mahony and Gareth Powell are long time, successful life sciences and healthcare investors. They are luminaries of the UK and European healthcare ecosystem, who have been investing since the late 1990s and initially worked together at Polar Capital where together they set up the biotech and healthcare investment funds. Gareth is still Head of […]